Dr. Frank Hensel – Principal / Authorized signatory
Dr Frank Hensel is Investment Manager, scientist and founder of OncoMab GmbH, a spin-off of the University of Würzburg’s Institute of Pathology. The expert for tumour-reactive antibodies brings with him significant experience in biotechnology. His focus lies in the development of biologicals from the manufacturing phase to the clinical-trial stage.
+49 – (0)228 – 82300 – 142